Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: The effect of insulin

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Li, Jilin ^a,b   Jin, Chunhua ^a,b   Cleveland Jr, Joseph C ^a   Ao, Lihua ^a   Xu, Dingli ^b   Fullerton, David A ^a   Meng, Xianzhong ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HORMONE ACTION; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 78650137830     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-90     Document Type: Article

References (52)

1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999, 340:115-126. 10.1056/NEJM199901143400207, 9887164.
2. Gustafson B. Adipose Tissue, Inflammation and Atherosclerosis. J Atheroscler Thromb 2010, 17:332-41.
3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695. 10.1056/NEJMra043430, 15843671.
4. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992, 6:2591-2599.
5. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990, 50:537-544. 10.1097/00007890-199010000-00001, 2219269.
6. Donahue RP, Orchard TJ. Diabetes mellitus and macrovascular complications. An epidemiological perspective. Diabetes Care 1992, 15:1141-1155. 10.2337/diacare.15.9.1141, 1396012.
7. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987, 59:750-755. 10.1016/0002-9149(87)91086-1, 3825934.
8. Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003, 16:637-646. 10.1128/CMR.16.4.637-646.2003, 207104, 14557290.
9. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680. 10.1038/90609, 11477402.
10. Curtiss LK, Tobias PS. Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res 2009, 50(Suppl):S340-345. 10.1194/jlr.R800056-JLR200, 2674724, 18980945.
11. Katsargyris A, Theocharis SE, Tsiodras S, Giaginis K, Bastounis E, Klonaris C. Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques. Expert Opin Ther Targets 2010, 14:1-10. 10.1517/14728220903401294, 20001205.
12. Monaco C, Gregan SM, Navin TJ, Foxwell BM, Davies AH, Feldmann M. Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation 2009, 120:2462-2469. 10.1161/CIRCULATIONAHA.109.851881, 19948979.
13. Burleigh ME, Babaev VR, Yancey PG, Major AS, McCaleb JL, Oates JA, Morrow JD, Fazio S, Linton MF. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. J Mol Cell Cardiol 2005, 39:443-452. 10.1016/j.yjmcc.2005.06.011, 16040051.
14. Nakagawa H, Tsunooka N, Yamamoto Y, Yoshida M, Nakata T, Kawachi K. Intestinal ischemia/reperfusion-induced bacterial translocation and lung injury in atherosclerotic rats with hypoadiponectinemia. Surgery 2009, 145:48-56. 10.1016/j.surg.2008.07.018, 19081475.
15. Moon PD, Jeong HJ, Um JY, Kim HM, Hong SH. LPS-induced inflammatory cytokine production was inhibited by HyungbangJihwangTang through blockade of NF-kappaB in peripheral blood mononuclear cells. Int J Neurosci 2007, 117:1315-1329. 10.1080/00207450600936692, 17654094.
16. Wiken M, Grunewald J, Eklund A, Wahlstrom J. Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol 2009, 29:78-89. 10.1007/s10875-008-9225-0, 18773284.
17. Lien E, Zipris D. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr Mol Med 2009, 9:52-68. 10.2174/156652409787314453, 19199942.
18. Mohammad MK, Morran M, Slotterbeck B, Leaman DW, Sun Y, Grafenstein H, Hong SC, McInerney MF. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol 2006, 18:1101-1113. 10.1093/intimm/dxl045, 16728431.
19. Ghanim H, Mohanty P, Deopurkar R, Sia CL, Korzeniewski K, Abuaysheh S, Chaudhuri A, Dandona P. Acute modulation of toll-like receptors by insulin. Diabetes Care 2008, 31:1827-1831. 10.2337/dc08-0561, 2518353, 18556339.
20. Jagannathan M, McDonnell M, Liang Y, Hasturk H, Hetzel J, Rubin D, Kantarci A, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010, 53:1461-71. 10.1007/s00125-010-1730-z, 2895399, 20383694.
21. Li JM, Mullen AM, Shah AM. Phenotypic properties and characteristics of superoxide production by mouse coronary microvascular endothelial cells. J Mol Cell Cardiol 2001, 33:1119-1131. 10.1006/jmcc.2001.1372, 11444917.
22. Ao L, Song Y, Fullerton DA, Dinarello CA, Meng X. The interaction between myocardial depressant factors in endotoxemic cardiac dysfunction: role of TNF-alpha in TLR4-mediated ICAM-1 expression. Cytokine 2007, 38:124-129. 10.1016/j.cyto.2007.05.018, 2727933, 17683945.
23. Shames BD, Barton HH, Reznikov LL, Cairns CB, Banerjee A, Harken AH, Meng X. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock 2002, 17:114-119. 10.1097/00024382-200202000-00006, 11837786.
24. Zou N, Ao L, Cleveland JC, Yang X, Su X, Cai GY, Banerjee A, Fullerton DA, Meng X. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2008, 294:H2805-2813. 10.1152/ajpheart.00299.2008, 18441202.
25. Leffler M, Hrach T, Stuerzl M, Horch RE, Herndon DN, Jeschke MG. Insulin attenuates apoptosis and exerts anti-inflammatory effects in endotoxemic human macrophages. J Surg Res 2007, 143:398-406. 10.1016/j.jss.2007.01.030, 17583747.
26. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216. 10.1146/annurev.immunol.20.083001.084359, 11861602.
27. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947-950. 10.1038/ni712, 11547333.
28. Janeway CA. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992, 13:11-16. 10.1016/0167-5699(92)90198-G, 1739426.
29. Tousoulis D, Antoniades C, Koumallos N, Stefanadis C. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev 2006, 17:225-233. 10.1016/j.cytogfr.2006.04.003, 16750416.
30. Jehle AB, Li Y, Stechschulte AC, Stechschulte DJ, Dileepan KN. Endotoxin and mast cell granule proteases synergistically activate human coronary artery endothelial cells to generate interleukin-6 and interleukin-8. J Interferon Cytokine Res 2000, 20:361-368. 10.1089/107999000312298, 10805370.
31. Zeuke S, Ulmer AJ, Kusumoto S, Katus HA, Heine H. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res 2002, 56:126-134. 10.1016/S0008-6363(02)00512-6, 12237173.
32. Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ. Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia 2006, 49:766-774. 10.1007/s00125-005-0102-6, 16463048.
33. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 2007, 3:853-876. 2350146, 18200806.
34. Searls YM, Loganathan R, Smirnova IV, Stehno-Bittel L. Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia. Cardiovasc Diabetol 2010, 9:8. 10.1186/1475-2840-9-8, 2829469, 20122173.
35. Westerweel PE, van Velthoven CT, Nguyen TQ, den Ouden K, de Kleijn DP, Goumans MJ, Goldschmeding R, Verhaar MC. Modulation of TGF-beta/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model. Cardiovasc Diabetol 2010, 9:55. 10.1186/1475-2840-9-55, 2954908, 20858224.
36. Schuster JM, Nelson PS. Toll receptors: an expanding role in our understanding of human disease. J Leukoc Biol 2000, 67:767-773.
37. Dziarski R. Recognition of bacterial peptidoglycan by the innate immune system. Cell Mol Life Sci 2003, 60:1793-1804. 10.1007/s00018-003-3019-6, 14523544.
38. Ianaro A, Tersigni M, D'Acquisto F. New insight in LPS antagonist. Mini Rev Med Chem 2009, 9:306-317.
39. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071. 10.1056/NEJM199704103361506, 9091804.
40. Granet C, Maslinski W, Miossec P. Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. Arthritis Res Ther 2004, 6:R190-198. 10.1186/ar1159, 416439, 15142264.
41. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Me tab 2008, 93:578-583.
42. Andreakos E, Sacre S, Foxwell BM, Feldmann M. The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis. Front Biosci 2005, 10:2478-2488. 10.2741/1712, 15970510.
43. Zawawi KH, Kantarci A, Schulze-Spate U, Fujita T, Batista EL, Amar S, Van Dyke TE. Moesin-induced signaling in response to lipopolysaccharide in macrophages. J Periodontal Res 2010, 45:589-601. 10.1111/j.1600-0765.2010.01271.x, 20546116.
44. Fan J, Frey RS, Malik AB. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 2003, 112:1234-1243. 213490, 14561708.
45. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001, 166:2018-2024.
46. Brown KL, Bylund J, MacDonald KL, Song-Zhao GX, Elliott MR, Falsafi R, Hancock RE, Speert DP. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol 2008, 129:90-102. 10.1016/j.clim.2008.06.005, 18676204.
47. Chisalita SI, Nitert MD, Arnqvist HJ. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells. Growth Horm IGF Res 2006, 16:258-266. 10.1016/j.ghir.2006.06.003, 16914341.
48. Rask-Madsen C, Li Q, Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Me tab 2010, 11:379-389.
49. Han J, Zhang F, Xie J, Linhardt RJ, Hiebert LM. Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin. Cardiovasc Diabetol 2009, 8:46. 10.1186/1475-2840-8-46, 2739842, 19695080.
50. Kidd LB, Schabbauer GA, Luyendyk JP, Holscher TD, Tilley RE, Tencati M, Mackman N. Insulin activation of the phosphatidylinositol 3-kinase/protein kinase B (Akt) pathway reduces lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther 2008, 326:348-353. 10.1124/jpet.108.138891, 2836781, 18445780.
51. Savoia C, Schiffrin EL. Inhibition of the renin angiotensin system: implications for the endothelium. Curr Diab Rep 2006, 6:274-278. 10.1007/s11892-006-0060-5, 16879778.
52. Csiszar A, Labinskyy N, Jo H, Ballabh P, Ungvari Z. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. Am J Physiol Heart Circ Physiol 2008, 295:H569-577. 10.1152/ajpheart.00180.2008, 2519199, 18539760.